Research
Calls for R+D+i
HORIZON-HLTH-2022-TOOL-11-01 Optimising effectiveness in patients of existing prescription drugs for major diseases (except cancer) with the use of biomarkers. Single stage.
Type of action: RIA
Single/2 stage: Single stage
Programme budget: 60 M€
Expected EU contribution/ project (M€): ≈ 10 M€
Nº projects expected to be funded: 6
Deadline(s): 21/04/2022